| [1] |
YU Gongqi, YUE Shan, YU Yongxiang, HE Yanqing, ZHAO Qing, PAN Qing, YANG Yilin, WANG Chuan, LIU Hong.
Allergen sensitization profiles in allergic dermatitis patients: a retrospective clinical analysis of 3793 cases
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 147-151.
|
| [2] |
LI Furong, GAO Jingya, LI Mengmeng, WANG Yiyi, XIAO Yue, LI Wei.
Castleman disease following TNF-α inhibitor therapy for psoriatic arthritis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 196-199.
|
| [3] |
SHAO Yuling, WANG Na.
Successful treatment of dupilumab-associated nail psoriasis with upadacitinib: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 206-210.
|
| [4] |
BAI Fan, YU Wanlong, WEI Yuming, XU Yabo, LEI Mingjun.
Successful treatment of adalimumab-induced generalized pustular psoriasis with guselkumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(2): 97-100.
|
| [5] |
HU Junjie, WU Yifan, TANG Huayang.
Post-translational modifications and psoriasis: from molecular mechanisms to therapeutic targets
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(2): 139-144.
|
| [6] |
LI Xin, WANG Jun, MIAO Guoying, ZHANG Jianzhong, LI Lingyu.
Development of a relapse prediction model for psoriasis vulgaris based on serum TARC, CCL19 and LRG1 levels
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 30-34.
|
| [7] |
WANG Yanzhen, CHEN Jing.
Secukinumab in the treatment of erythrodermic psoriasis with chronic hepatitis C: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 53-55.
|
| [8] |
GAO Jingya, HU Hongxiang, XIAO Yue, XIA Dengmei, JIANG Lu, LI Wei.
Clinical analysis of 8 cases with plaque psoriasis complicated by HIV infected treated with biologics
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 559-563.
|
| [9] |
HE Xiaojun, HAN Junya, WANG Decheng, HUANG Yaqun, FANG Xianfeng.
Analysis of factors influencing the treatment of moderate to severe plaque psoriasis with secukinumab
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 571-577.
|
| [10] |
WU Dandan, ZHU Qingying, YIN Bin.
Pathogenesis of tinea capitis from the multidimensional perspective of dermatophytes-host-microecology
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 620-625.
|
| [11] |
QI Chunyan, SHE Xinyan, CAI Liting, GUAN Zepu, WANG Xiaohua, QIU Xiaoyu.
Characteristics and severity correlation analysis of nail damage in moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 400-405.
|
| [12] |
WU Qiaofang, BAO Jun, SUN Yuexin, TAO Yue.
Efficacy and safety of tildrakizumab in the treatment of 32 patients with moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 410-415.
|
| [13] |
YU Wanlong, BAI Fan, YANG Yinan, LI Shuangshuang, XU Yabo, CHANG Feiyu, LEI Mingjun.
Generalised pustular psoriasis with alopecia treated with deucravacitinib: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 450-452.
|
| [14] |
HU Hongxiang, GAO Jingya, ZHOU Xingli, LI Wei.
Guselkumab for the treatment of psoriasis combined with AIDS and hepatitis C: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 276-278.
|
| [15] |
ZHOU Sijie, ZHOU Peimei.
Update of the treatment for chronic spontaneous urticaria
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(4): 298-302.
|